Literature DB >> 15920935

Subcutaneous administration of drugs in the elderly: survey of practice and systematic literature review.

Caroline Fonzo-Christe1, Caroline Vukasovic, Anne-Florence Wasilewski-Rasca, Pascal Bonnabry.   

Abstract

OBJECTIVES AND
METHOD: Survey of subcutaneous drug use and hypodermoclysis with a standardized questionnaire to 27 nursing teams and 52 physicians in a geriatric hospital department (404 beds). Evaluation of license status (CH, F, D and UK) and systematic literature review of 34 drugs used in the geriatric setting.
RESULTS: Subcutaneous route is used daily with drugs and fluids mostly for patients in palliative care (83%) or who are dehydrated (54%) when oral or IV administration is impossible (73%, 68% respectively). Morphine (98%), haloperidol (90%), furosemide (69%) and hydromorphone (56%) by bolus (36%) or slow injection over 5 min (82%) are the main drugs used and NaCI 0.9% (95%), and glucose 5%/NaCI 0.9% (31 %) are commonly used for rehydration. Among the 34 drugs reviewed, only 13 (38%) are licensed for subcutaneous use in CH, UK, F or D, and only, morphine (14 articles of 68) and rehydration (six articles) are evaluated in high level studies. Haloperidol and furosemide are used off-label and there are no well-designed studies supporting their subcutaneous use.
CONCLUSION: There is a lack of information on drugs widely used by subcutaneous route in the elderly. In that context, physicians carry responsibility for the prescription.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920935     DOI: 10.1191/0269216304pm1006oa

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  8 in total

1.  Pharmacokinetics of ertapenem following intravenous and subcutaneous infusions in patients.

Authors:  Denis Frasca; Sandrine Marchand; Franck Petitpas; Claire Dahyot-Fizelier; William Couet; Olivier Mimoz
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

2.  "Palliative Syringe Driver"? A Mixed-Methods Study in Different Hospital Departments on Continuous Infusions of Sedatives and/or Opioids in End-of-Life Care.

Authors:  Sophie Meesters; Bettina Grüne; Claudia Bausewein; Eva Schildmann
Journal:  J Patient Saf       Date:  2022-06-01       Impact factor: 2.243

3.  Medication use during end-of-life care in a palliative care centre.

Authors:  Anniek D Masman; Monique van Dijk; Dick Tibboel; Frans P M Baar; Ron A A Mathôt
Journal:  Int J Clin Pharm       Date:  2015-04-09

Review 4.  Hypodermoclysis: a literature review to assist in clinical practice.

Authors:  Vanessa Galuppo Bruno
Journal:  Einstein (Sao Paulo)       Date:  2015-03-24

5.  Evaluation of efficacy and safety of subcutaneous acetaminophen in geriatrics and palliative care (APAPSUBQ).

Authors:  Joe El Khoury; Sani Hlais; Mariana Helou; Marie-Claire Mouhawej; Serge Barmo; Patricia Fadel; Aline Tohme
Journal:  BMC Palliat Care       Date:  2022-03-26       Impact factor: 3.234

6.  Evidence for the use of Levomepromazine for symptom control in the palliative care setting: a systematic review.

Authors:  Isabel Dietz; Andrea Schmitz; Ingrid Lampey; Christian Schulz
Journal:  BMC Palliat Care       Date:  2013-01-19       Impact factor: 3.234

7.  A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea.

Authors:  Ralph J Johnson
Journal:  BMC Psychiatry       Date:  2018-04-03       Impact factor: 3.630

8.  Intravenous versus subcutaneous route pharmacokinetics of paracetamol (acetaminophen) in palliative care patients: study protocol for a randomized trial (ParaSCIVPallia).

Authors:  Marine Vernant; Marie Lepoupet; Christian Creveuil; Antoine Alix; Charlotte Gourio; Laure Peyro-Saint-Paul; Veronique Lelong-Boulouard; Cyril Guillaumé
Journal:  Trials       Date:  2020-02-04       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.